date: 2019-03-22T07:14:39Z
pdf:PDFVersion: 1.5
pdf:docinfo:title: Between Innate and Adaptive Immune Responses: NKG2A, NKG2C, and CD8+ T Cell Recognition of HLA-E Restricted Self-Peptides Acquired in the Absence of HLA-Ia
xmp:CreatorTool: LaTeX with hyperref package
access_permission:can_print_degraded: true
subject: On healthy cells the non-classical HLA class Ib molecule HLA-E displays the cognate ligand for the NK cell receptor NKG2A/CD94 when bound to HLA class I signal peptide sequences. In a pathogenic situation when HLA class I is absent, HLA-E is bound to a diverse set of peptides and enables the stimulatory NKG2C/CD94 receptor to bind. The activation of CD8+ T cells by certain p:HLA-E complexes illustrates the dual role of this low polymorphic HLA molecule in innate and adaptive immunity. Recent studies revealed a shift in the HLA-E peptide repertoire in cells with defects in the peptide loading complex machinery. We recently showed that HLA-E presents a highly diverse set of peptides in the absence of HLA class Ia and revealed a non-protective feature against NK cell cytotoxicity mediated by these peptides. In the present study we have evaluated the molecular basis for the impaired NK cell inhibition by these peptides and determined the cell surface stability of individual p:HLA-E complexes and their binding efficiency to soluble NKG2A/CD94 or NKG2C/CD94 receptors. Additionally, we analyzed the recognition of these p:HLA-E epitopes by CD8+ T cells. We show that non-canonical peptides provide stable cell surface expression of HLA-E, and these p:HLA-E complexes still bind to NKG2/CD94 receptors in a peptide-restricted fashion. Furthermore, individual p:HLA-E complexes elicit activation of CD8+ T cells with an effector memory phenotype. These novel HLA-E epitopes provide new implications for therapies targeting cells with abnormal HLA class I expression.
dc:format: application/pdf; version=1.5
pdf:docinfo:creator_tool: LaTeX with hyperref package
access_permission:fill_in_form: true
pdf:encrypted: false
dc:title: Between Innate and Adaptive Immune Responses: NKG2A, NKG2C, and CD8+ T Cell Recognition of HLA-E Restricted Self-Peptides Acquired in the Absence of HLA-Ia
modified: 2019-03-22T07:14:39Z
cp:subject: On healthy cells the non-classical HLA class Ib molecule HLA-E displays the cognate ligand for the NK cell receptor NKG2A/CD94 when bound to HLA class I signal peptide sequences. In a pathogenic situation when HLA class I is absent, HLA-E is bound to a diverse set of peptides and enables the stimulatory NKG2C/CD94 receptor to bind. The activation of CD8+ T cells by certain p:HLA-E complexes illustrates the dual role of this low polymorphic HLA molecule in innate and adaptive immunity. Recent studies revealed a shift in the HLA-E peptide repertoire in cells with defects in the peptide loading complex machinery. We recently showed that HLA-E presents a highly diverse set of peptides in the absence of HLA class Ia and revealed a non-protective feature against NK cell cytotoxicity mediated by these peptides. In the present study we have evaluated the molecular basis for the impaired NK cell inhibition by these peptides and determined the cell surface stability of individual p:HLA-E complexes and their binding efficiency to soluble NKG2A/CD94 or NKG2C/CD94 receptors. Additionally, we analyzed the recognition of these p:HLA-E epitopes by CD8+ T cells. We show that non-canonical peptides provide stable cell surface expression of HLA-E, and these p:HLA-E complexes still bind to NKG2/CD94 receptors in a peptide-restricted fashion. Furthermore, individual p:HLA-E complexes elicit activation of CD8+ T cells with an effector memory phenotype. These novel HLA-E epitopes provide new implications for therapies targeting cells with abnormal HLA class I expression.
pdf:docinfo:subject: On healthy cells the non-classical HLA class Ib molecule HLA-E displays the cognate ligand for the NK cell receptor NKG2A/CD94 when bound to HLA class I signal peptide sequences. In a pathogenic situation when HLA class I is absent, HLA-E is bound to a diverse set of peptides and enables the stimulatory NKG2C/CD94 receptor to bind. The activation of CD8+ T cells by certain p:HLA-E complexes illustrates the dual role of this low polymorphic HLA molecule in innate and adaptive immunity. Recent studies revealed a shift in the HLA-E peptide repertoire in cells with defects in the peptide loading complex machinery. We recently showed that HLA-E presents a highly diverse set of peptides in the absence of HLA class Ia and revealed a non-protective feature against NK cell cytotoxicity mediated by these peptides. In the present study we have evaluated the molecular basis for the impaired NK cell inhibition by these peptides and determined the cell surface stability of individual p:HLA-E complexes and their binding efficiency to soluble NKG2A/CD94 or NKG2C/CD94 receptors. Additionally, we analyzed the recognition of these p:HLA-E epitopes by CD8+ T cells. We show that non-canonical peptides provide stable cell surface expression of HLA-E, and these p:HLA-E complexes still bind to NKG2/CD94 receptors in a peptide-restricted fashion. Furthermore, individual p:HLA-E complexes elicit activation of CD8+ T cells with an effector memory phenotype. These novel HLA-E epitopes provide new implications for therapies targeting cells with abnormal HLA class I expression.
pdf:docinfo:creator: Wiebke C. Pump, Thomas Kraemer, Trevor Huyton, Gia-Gia T. Hò, Rainer Blasczyk and Christina Bade-Doeding
PTEX.Fullbanner: This is pdfTeX, Version 3.14159265-2.6-1.40.18 (TeX Live 2017/W32TeX) kpathsea version 6.2.3
meta:author: Wiebke C. Pump, Thomas Kraemer, Trevor Huyton, Gia-Gia T. Hò, Rainer Blasczyk and Christina Bade-Doeding
trapped: False
meta:creation-date: 2019-03-22T07:14:39Z
created: 2019-03-22T07:14:39Z
access_permission:extract_for_accessibility: true
Creation-Date: 2019-03-22T07:14:39Z
Author: Wiebke C. Pump, Thomas Kraemer, Trevor Huyton, Gia-Gia T. Hò, Rainer Blasczyk and Christina Bade-Doeding
producer: pdfTeX-1.40.18
pdf:docinfo:producer: pdfTeX-1.40.18
pdf:unmappedUnicodeCharsPerPage: 17
Keywords: Immune Evasion hCMV; NKG2A/CD94; NKG2C/CD94; HLA-E peptide ligands
access_permission:modify_annotations: true
dc:creator: Wiebke C. Pump, Thomas Kraemer, Trevor Huyton, Gia-Gia T. Hò, Rainer Blasczyk and Christina Bade-Doeding
dcterms:created: 2019-03-22T07:14:39Z
Last-Modified: 2019-03-22T07:14:39Z
dcterms:modified: 2019-03-22T07:14:39Z
title: Between Innate and Adaptive Immune Responses: NKG2A, NKG2C, and CD8+ T Cell Recognition of HLA-E Restricted Self-Peptides Acquired in the Absence of HLA-Ia
Last-Save-Date: 2019-03-22T07:14:39Z
pdf:docinfo:keywords: Immune Evasion hCMV; NKG2A/CD94; NKG2C/CD94; HLA-E peptide ligands
pdf:docinfo:modified: 2019-03-22T07:14:39Z
meta:save-date: 2019-03-22T07:14:39Z
pdf:docinfo:custom:PTEX.Fullbanner: This is pdfTeX, Version 3.14159265-2.6-1.40.18 (TeX Live 2017/W32TeX) kpathsea version 6.2.3
Content-Type: application/pdf
X-Parsed-By: org.apache.tika.parser.DefaultParser
creator: Wiebke C. Pump, Thomas Kraemer, Trevor Huyton, Gia-Gia T. Hò, Rainer Blasczyk and Christina Bade-Doeding
dc:subject: Immune Evasion hCMV; NKG2A/CD94; NKG2C/CD94; HLA-E peptide ligands
access_permission:assemble_document: true
xmpTPg:NPages: 15
pdf:charsPerPage: 2993
access_permission:extract_content: true
access_permission:can_print: true
pdf:docinfo:trapped: False
meta:keyword: Immune Evasion hCMV; NKG2A/CD94; NKG2C/CD94; HLA-E peptide ligands
access_permission:can_modify: true
pdf:docinfo:created: 2019-03-22T07:14:39Z